Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for April 2007
April 2, 2007
- Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
- Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
- Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
- Six Important Things to Know About Preventing Hospital Infections
- NeoPharm Provides Update on LE-SN38 Program
- Immunosuppressant Drug Prevents Tobacco Induced Lung Cancer in Mice
- Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
- M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data at the AACR Annual Meeting
- Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
- State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
- NIDA Study Identifies Genes That Might Help Some People Abstain from Smoking
- Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
April 3, 2007
- Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
- Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
- Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
- Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
- Repros' Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
- Latest NIMH Study on Bipolar Disorder
- Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
- Pharmasset Announces Clevudine and Hepatitis C Presentations at EASL
- New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
- PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research
- Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
- New Data Confirm That Use of Levemir Can Limit Weight Gain
- Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting
- Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's Conference
- Rapid Response was Crucial to Containing the 1918 Flu Pandemic
- Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research
- Scientific Results Presented At ECCMID Demonstrate Well- Differentiated Profile of Basilea's Two Phase III Anti- infective Compounds
April 4, 2007
- CytoGenix Announces Successful Testing of synDNA Vaccine for Avian Influenza Virus
- Novagali Pharma Announces Positive Vekacia Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis
- ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
- Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
- Icagen Terminates Phase III ASSERT Study
- New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
- Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
- CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
- Eurand Announces Positive Phase III Clinical Study Results
- Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
- Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
- SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at AACR
- ARIUS to Present at American Association for Cancer Research Annual Meeting
- CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to be Presented on June 3, 2007
- Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
April 5, 2007
- Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment
- Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
- Researchers Identify Intracellular Pathway of Alfacell's Onconase
- The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
- New Cardioprotective Drug Could Provide Boost For Post-Bypass Surgery Heart Health
April 6, 2007
April 9, 2007
- Nereus Pharmaceuticals to Present Data at the American Association for Cancer Research 2007 Annual Meeting
- Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival Benefits as Mitigator Against Radiation-Induced Damage in Study
- The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better
- Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
April 10, 2007
- GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (Entereg/Entrareg)
- Nasulin Interim Results to Be Presented at American Diabetes Association Scientific Sessions
- Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
- Inotek Pharmaceuticals Announces Publication of Animal Data from Study of PARP Inhibition as Potential Preventative of Brain Injury Following Stroke
- Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
- Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
- First-of-its-Kind National Report Reveals Estimated High Prevalence and Heavy Cost of Type 2 Diabetes Complications in America
- Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
- Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2007 Annual Meeting
- Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
- Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases
- Study Shows Children With ADHD Who Start on Strattera are More Likely to Change Therapies
April 11, 2007
- InterMune Presents Research on ITMN-191 in Hepatitis C at EASL Annual Meeting
- Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds
- Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
- Vertex Pharmaceuticals Announces New Data for Investigational HCV Protease Inhibitor Telaprevir to be Presented at 42nd Annual Meeting of the European Association for the Study of the Liver (EASL)
- First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
- New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
- Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR
- Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
- Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
- Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
- Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
- Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
- Newest Adult Stem Therapy Treats Diabetes
- Fragile X, Down Syndromes Linked to Faulty Brain Communication, Stanford Researcher Finds
- Innovive Pharmaceuticals Announces Data from Oncology Drug Programs to be Presented at American Association for Cancer Research Annual Meeting
- Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2 Study Data in Neurology
April 12, 2007
- DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
- Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
- Innovive Pharmaceuticals Announces Additional Data Presentations at American Association for Cancer Research Annual Meeting
- Affymax Announces Results From Phase 2 Clinical Trial of Hematide for the Treatment of Anemia in Dialysis Patients
- CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
- Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
- Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
- AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
- Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
- Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
- Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying to Control It Later
April 13, 2007
- ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants
- Enzon to Present Preclinical Data From PEG-SN38 and PEGylation Technology Studies at AACR Meeting
- Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
- Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment
- Ascenta Therapeutics Highlights Multiple Data Presentations at Upcoming AACR Annual Meeting
- Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
- Gentium's Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
- Point Therapeutics Announces Preclinical Data Presentations at Upcoming American Association of Cancer Research Annual Meeting
- Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount System for Automated Cell Counting at AACR
- Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
- Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
- Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
- ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver
- AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
- Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
- New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
- CombinatoRx to Present Combination High Throughput Screening (cHTS) Data at Upcoming AACR Meeting
- DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3)
- Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the American Association of Cancer Research Annual Meeting in Los Angeles
- Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual Meeting of the American Association of Cancer Research (AACR)
- UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study Shows
April 16, 2007
- Rigel to Present New Research Programs at AACR Meeting
- AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
- ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
- Poster on Cyclosert Drug Delivery Presented at AACR Meeting
- Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
- Novelos Therapeutics and MUSC Present Two Posters at AACR 2007 Annual Meeting
- Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C
- Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
- Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
- AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
- Sunesis Presents Data Supporting SNS-032's Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
- Data supporting three Antisoma programmes presented at AACR
- Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
- Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
- Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
- Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
- ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
- Somanta Announces the Presentation of Alchemix Data at The American Association for Cancer Research Annual Meeting
- Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
- Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
- Threshold Pharmaceuticals Announces Multiple Presentations on Oncology Pipeline at the 2007 American Association for Cancer Research (AACR) Annual Meeting
- Achillion Presents Positive Data on Novel Mechanism for Treating HCV at EASL Annual Meeting
- Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
- Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
- Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
- Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
- Biomira Selects PX-866 as Clinical Development Candidate and Presents Promising Preclinical Data at AACR
- Onconova Therapeutics Announces Presentation of Clinical and Non-Clinical Results for Its Lead Compound ON 01910.Na at American Association of Cancer Research Conference in Los Angeles
- Bionovo to Present Recent Findings of BZL101, Its Anti-cancer Agent, at the American Association of Cancer Research
- Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
- Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting
- EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
- Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
- Progen's Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
- Karmanos Physician-Scientists Examine Racial Disparities in Patients with Gynecologic Cancer
- Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
April 17, 2007
- AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
- Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
- EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
- GTx Announces Ostarine Improved Insulin Resistance among Elderly Patients in a Recently Completed Phase II Clinical Trial
- Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
- Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
- GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy
- ProNAi Announces Preclinical Success for PNT2258 Therapeutic - Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
- Curis Announces Hedgehog and Wnt Antagonist Data Presentation at AACR
- ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
- Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
- Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
- Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
- AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
- Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines
- Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
- OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
- Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells
- Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
- Alzheimer's Drug Shows Promise in Fighting Cancer
- Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
- Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
- Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
- ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
- Æterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
- Data on Higher Dose of Copaxone and Data Showing Copaxone is Most Cost Effective
- Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
- Myriad Genetics Presents Azixa's Mode of Action at AACR
April 18, 2007
- Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Bruton's Tyrosine Kinase Inhibitors
- Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
- Gemin X Presents Positive Preclinical Data of GX15-070 in Infant ALL at AACR Meeting
- Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
- Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at AACR
- Data Presented at AACR Meeting Show Peregrine's Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
- EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
- Aeolus Pharmaceuticals' AEOL 10150 Highlighted in Nature Genetics Publication
- Ferring Reports on ENDOMETRIN Presentations at Pacific Coast Reproductive Society Annual Meeting
- Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207 for BPH
- Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
- Innovive Pharmaceuticals Announces Preclinical Data from INNO-206 Oncology Program
- Viventia biotech reports synergystic effect of its Proxinium antibody in combinaton with chemotherapy and radiation
- Adventrx Announces Positive Data From Multidrug Therapy With CoFactor
- Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
- Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
- Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
- Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
- Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
- Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
- Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
- Micell Technologies Presents Data on Novel Drug-Eluting Stents
- FDA Announces Change of Location Notice for Upcoming Advisory Committee Meeting
- Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib Combination in Non-Small Cell Lung Cancer Presented at American Association of Cancer Research Annual Meeting
- Myriad Genetics Presents Tumor Origin Technology at AACR
- Novel Human Tissue Transgenic Cancer Model May Offer Significant Advance Toward Accurately Modeling Human Cancer
April 19, 2007
- Antares Pharma Announces Positive Results from Application Site Study for Anturol
- ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
- Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
- MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
- CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
- EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
- Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
- Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycin's Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
- Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
- Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
- Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
- Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV
- King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide
- Aranesp ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
- Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
- Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
- Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
- Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
- Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting
- MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
- LANI completes Phase I in Japan and to commence Phase I in UK
- VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
April 20, 2007
- Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
- Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
- New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
- Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
- UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
- The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
- Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
- Peregrine Pharmaceuticals Highlights Significant Advances in the Company's Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
- FDA Announces Audio Broadcasts on Emerging Drug Safety Information
April 23, 2007
- Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
- Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
- Ceragenix Announces New Publication of Scientific Research on Ceragenin Technology
- Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
- CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
- Sirion Therapeutics Announces Clinical Data to be Presented at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
- FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer
- Mircera Effective in Stabilising Haemoglobin Levels in Elderly Patients With Kidney Disease on Dialysis
- Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells
- Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
- Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
- Gentium's Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
April 24, 2007
- New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
- Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of Neurology Annual Meeting
- Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
- Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints
- Accera, Inc. to Present Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
- Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment
- FDA approves MyocondaR IND for MAP in Crohn's Disease
- Cortex Area Thinner in Youth with Alzheimers-Related Gene
April 25, 2007
- Telomerase Presentations at the AACR 2007 Annual Meeting
- Acorda Therapeutics to Host Analyst and Investor Reception
- BDSI Announces Positive Phase III Clinical Trial Results for BEMA Fentanyl
- ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
- Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
- XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
- DuoCort AB: DuoCort announces Phase I Data Presentation at the European Congress of Endocrinology
- Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer
- Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgen's INGN 241
- OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
- New Data on Genmab and GlaxoSmithKline's Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
- Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
- Labtec’s Next Generation Pain Patch Successful in Clinical Studies
April 26, 2007
- Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
- Major Manufacturer of Unapproved and Adulterated Drugs
- Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers' Diarrhea Stimulates Immune Response Even at Low Doses
- Study Demonstrating Aeolus Compound's Neuroprotection in Parkinson's Disease Published in the Journal of Neuroscience
- Study Supports Cost-Effectiveness of Medtronic's Spasticity Treatment for Children with Cerebral Palsy
- Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP Phase II Trial
- Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
- Schepens Scientists Identify Key to Integrating Transplanted Nerve Cells Into Injured Tissue
- FDA approves IND on Lead Product M6G
- Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh to be Presented at European Vascular Symposium
- Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
April 27, 2007
- Doctors Outraged Over Growth Hormone Controversy
- Northfield Laboratories Investor Update
- First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
- Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
- Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
- Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
- SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
- Merck Serono Announces Presentation of Phase III Clinical Data on Safinamide in Parkinson’s Disease at the American Academy of Neurology 59th Annual Meeting
April 30, 2007
- Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
- Cobalis Expects to Report Phase III Top-Line Results in May
- Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
- New Report Illuminates Ampligen's Unique Mechanism of Action
- Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
- Evidence of Nanoparticles Found in Plaque-Filled Arteries
- Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance
- Apollo develops needle-free topical vaccine
- Ad hoc: Interim report about clinical trial of BF-200 ALA in actinic keratosis
